Rapid modification of retroviruses using lipid conjugates

Nanotechnology

Volumn 20, Issue 6, 2009, Pages

  Mukherjee, Nimisha G ^a   Andrew Lyon, L ^a,b   Le Doux, Joseph M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Parker H Petit Institute of Bioengineering and Bioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR DELIVERIES; GENE THERAPIES; PHOSPHOETHANOLAMINE; STREPTAVIDIN;

ETHYLENE GLYCOL; GENETIC ENGINEERING; MICROORGANISMS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

ONCOGENIC VIRUSES;

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [BIOTINYL(POLYETHYLENE GLYCOL) 2000] CONJUGATE; BIOTIN; CAPSID PROTEIN; GREEN FLUORESCENT PROTEIN; LIPID; MACROGOL; MACROGOL DERIVATIVE; NANOPARTICLE; RHODAMINE; STREPTAVIDIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; PHOSPHOLIPID;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CONJUGATION; CONTROLLED STUDY; DISSOCIATION; HELA CELL; HUMAN; HUMAN CELL; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RETROVIRUS; VIRUS ATTACHMENT; VIRUS INFECTIVITY; VIRUS PARTICLE; CELL LINE; CHEMISTRY; METABOLISM; VIRAL PHENOMENA AND FUNCTIONS;

CELL LINE; HUMANS; PHOSPHOLIPIDS; RETROVIRIDAE; STREPTAVIDIN; VIRUS ATTACHMENT; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 65249173435     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/20/6/065103     Document Type: Article

References (53)

1. Andreadis S, Lavery T, Davis H E, Le Doux J M, Yarmush M L and Morgan J R 2000 Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection J. Virol. 74 3431-9 (Pubitemid 30044075)
2. Bethell D, Brust M, Schiffrin D J and Kiely C 1996 From monolayers to nanostructured materials: an organic chemist's view of self-assembly J. Electroanal. Chem. 409 137-43 (Pubitemid 126370428)
3. Blumenthal R, Gallo S A, Viard M, Raviv Y and Puri A 2002 Fluorescent lipid probes in the study of viral membrane fusion Chem. Phys. Lipids 116 39-55 (Pubitemid 34686986)
4. Boal A K and Rotello V M 2000 Fabrication and self-optimization of multivalent receptors on nanoparticle scaffolds J. Am. Chem. Soc. 122 734-5 (Pubitemid 30090521)
5. Boeckle S and Wagner E 2006 Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems AAPS J. 8 E731-42
6. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland F T and Krausslich H G 2006 The HIV lipidome: a raft with an unusual composition Proc. Natl Acad. Sci. USA 103 2641-6 (Pubitemid 43306602)
7. Chung H A, Kato K, Itoh C, Ohhashi S and Nagamune T 2004 Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions J. Biomed. Mater. Res. A 70 179-85 (Pubitemid 38988748)
8. Collins S A, Guinn B A, Harrison P T, Scallan M F, O'Sullivan G C and Tangney M 2008 Viral vectors in cancer immunotherapy: which vector for which strategy? Curr. Gene Ther. 8 66-78
9. Cosset F L, Takeuchi Y, Battini J L, Weiss R A and Collins M K 1995 High-titer packaging cells producing recombinant retroviruses resistant to human serum J. Virol. 69 7430-6
10. Croyle M A, Callahan S M, Auricchio A, Schumer G, Linse K D, Wilson J M, Brunner L J and Kobinger G P 2004 PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum J. Virol. 78 912-21 (Pubitemid 38067612)
11. Cullis P R and Chonn A 1998 Recent advances in liposome technologies and their applications for systemic gene delivery Adv. Drug Deliv. Rev. 30 73-83 (Pubitemid 28201906)
12. Dennis J E, Cohen N, Goldberg V M and Caplan A I 2004 Targeted delivery of progenitor cells for cartilage repair J. Orthop. Res. 22 735-41 (Pubitemid 38756251)
13. Elghanian R, Storhoff J J, Mucic R C, Letsinger R L and Mirkin C A 1997 Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles Science 277 1078-81 (Pubitemid 27371624)
14. Enoch H G and Strittmatter P 1979 Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles Proc. Natl Acad. Sci. USA 76 145-9
15. Etienne-Julan M, Roux P, Carillo S, Jeanteur P and Piechaczyk M 1992 The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker J. Gen. Virol. 73 3251-5 (Pubitemid 23014179)
16. Forster F, Medalia O, Zauberman N, Baumeister W and Fass D 2005 Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography Proc. Natl Acad. Sci. USA 102 4729-34 (Pubitemid 40471522)
17. Goff S P 2007 Host factors exploited by retroviruses Nat. Rev. Microbiol. 5 253-63 (Pubitemid 46443602)
18. Harlow H and Lane D 1998 Antibodies: A Laboratory Manual (Cold Spring Harbor: Cold Spring Harbor Laboratory Press)
19. Heyes J, Hall K, Tailor V, Lenz R and Maclachlan I 2006 Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery J. Control. Release 112 280-90
20. Hoekstra D, De Boer T, Klappe K and Wilschut J 1984 Fluorescence method for measuring the kinetics of fusion between biological membranes Biochemistry 23 5675-81 (Pubitemid 15189719)
21. Hoekstra D and Duzgunes N 1993 Lipid mixing assays to determine fusion in liposome systems Methods Enzymol. 220 15-32 (Pubitemid 223041721)
22. Huang C and Mason J T 1978 Geometric packing constraints in egg phosphatidylcholine vesicles Proc. Natl Acad. Sci. USA 75 308-10
23. Kafri T 2004 Gene delivery by lentivirus vectors an overview Methods Mol. Biol. 246 367-90
24. Kasahara N, Dozy A M and Kan Y W 1994 Tissue-specific targeting of retroviral vectors through ligand-receptor interactions Science 266 1373-6
25. Kato K, Itoh C, Yasukouchi T and Nagamune T 2004 Rapid protein anchoring into the membranes of Mammalian cells using oleyl chain and poly(ethylene glycol) derivatives Biotechnol. Prog. 20 897-904 (Pubitemid 38784030)
26. Landazuri N and Le Doux J M 2004 Complexation of retroviruses with charged polymers enhances gene transfer by increasing the rate that viruses are delivered to cells J. Gene Med. 6 1304-19 (Pubitemid 40287703)
27. Le Doux J M, Davis H E, Morgan J R and Yarmush M L 1999 Kinetics of retrovirus production and decay Biotechnol. Bioeng. 63 654-62 (Pubitemid 29200400)
28. Marandin A, Dubart A, Pflumio F, Cosset F L, Cordette V, Chapel-Fernandes S, Coulombel L, Vainchenker W and Louache F 1998 Retrovirus-mediated gene transfer into human CD34+ 38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo Hum. Gene Ther. 9 1497-511 (Pubitemid 28379089)
29. Marsh M and Helenius A 2006 Virus entry: open sesame Cell 124 729-40 (Pubitemid 43261448)
30. Mastrobattista E, Schoen P, Wilschut J, Crommelin D J and Storm G 2001 Targeting influenza virosomes to ovarian carcinoma cells FEBS Lett. 509 71-6 (Pubitemid 33153083)
31. Mok H, Palmer D J, Ng P and Barry M A 2005 Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses Mol. Ther. 11 66-79 (Pubitemid 40012000)
32. Neda H, Wu C H and Wu G Y 1991 Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity J. Biol. Chem. 266 14143-6
33. Overbaugh J, Miller A D and Eiden M V 2001 Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins Microbiol. Mol. Biol. Rev. 65 371-89 (Pubitemid 32881711)
34. Papisov M I 1998 Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions Adv. Drug Deliv. Rev. 32 119-38 (Pubitemid 28277179)
35. Pickl W F, Pimentel-Muinos F X and Seed B 2001 Lipid rafts and pseudotyping J. Virol. 75 7175-83 (Pubitemid 32641605)
36. Pownall H J and Smith L C 1989 Pyrene-labeled lipids: versatile probes of membrane dynamics in vitro and in living cells Chem. Phys. Lipids 50 191-211 (Pubitemid 19155048)
37. Rabuka D, Forstner M B, Groves J T and Bertozzi C R 2008 Noncovalent cell surface engineering: incorporation of bioactive synthetic glycopolymers into cellular membranes J. Am. Chem. Soc. 130 5947-53
38. Raschke G, Kowarik S, Franzl T, Sonnichsen C, Klar T A, Feldmann J, Nichtl A and Kurzinger L 2003 Biomolecular recognition based on single gold nanoparticle light scattering Nano Lett. 3 935-8 (Pubitemid 37161875)
39. Roux P, Jeanteur P and Piechaczyk M 1989 A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses Proc. Natl Acad. Sci. USA 86 9079-83 (Pubitemid 20010368)
40. Rovira-Bru M, Thompson D H and Szleifer I 2002 Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures Biophys. J. 83 2419-39 (Pubitemid 35265738)
41. Saul J M, Annapragada A, Natarajan J V and Bellamkonda R V 2003 Controlled targeting of liposomal doxorubicin via the folate receptor in vitro J. Control. Release 92 49-67 (Pubitemid 37130121)
42. Schutz G J, Kada G, Pastushenko V P and Schindler H 2000 Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy EMBO J. 19 892-901 (Pubitemid 30119815)
43. Smith J C, Lee K B, Wang Q, Finn M G, Johnson J E, Mrksich M and Mirkin C A 2003 Nanopatterning the chemospecific immobilization of cowpea mosaic virus capsid Nano Lett. 3 883-6 (Pubitemid 37161865)
44. Snitkovsky S and Young J A 2002 Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein Virology 292 150-5
45. Sommerfelt M A 1999 Retrovirus receptors J. Gen. Virol. 80 3049-64
46. Stegmann T, Morselt H W, Booy F P, Van Breemen J F, Scherphof G and Wilschut J 1987 Functional reconstitution of influenza virus envelopes EMBO J. 6 2651-9
47. Tailor C S, Lavillette D, Marin M and Kabat D 2003 Cell surface receptors for gammaretroviruses Curr. Top. Microbiol. Immunol 281 29-106 (Pubitemid 36950683)
48. Waehler R, Russell S J and Curiel D T 2007 Engineering targeted viral vectors for gene therapy Nat. Rev. Genet. 8 573-87 (Pubitemid 47077278)
49. Wang Q, Lin T, Tang L, Johnson J E and Finn M G 2002 Icosahedral virus particles as addressable nanoscale building blocks Angew. Chem. Int. Edn Engl. 41 459-62 (Pubitemid 34146072)
50. Woodle M C, Collins L R, Sponsler E, Kossovsky N, Papahadjopoulos D and Martin F J 1992 Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential Biophys. J. 61 902-10
51. Yamada T et al 2003 Nanoparticles for the delivery of genes and drugs to human hepatocytes Nat. Biotechnol. 21 885-90 (Pubitemid 36936193)
52. Zhao Y, Zhu L, Lee S, Li L, Chang E, Soong N W, Douer D and Anderson W F 1999 Identification of the block in targeted retroviral-mediated gene transfer Proc. Natl Acad. Sci. USA 96 4005-10 (Pubitemid 29169026)
53. Zufferey R, Nagy D, Mandel R J, Naldini L and Trono D 1997 Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat. Biotechnol. 15 871-5 (Pubitemid 127747819)